CIK: 0001782539 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 13, 2023
Total Value ($000): $145,137 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KARUNA THERAPEUTICS INC | 225,688 | $44,348 | 30.6% | $121.31 | — | COM | 48576A100 |
| ILMN | ILLUMINA INC | 119,196 | $24,101 | 16.6% | $459.88 | -54.9% | COM | 452327109 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 368,665 | $20,313 | 14.0% | $30.00 | +83.3% | COM | 413197104 |
| — | SEAGEN INC | 47,096 | $6,052 | 4.2% | $154.22 | — | COM | 81181C104 |
| REPL | REPLIMUNE GROUP INC | 189,339 | $5,150 | 3.5% | $18.17 | +14.3% | COM | 76029N106 |
| — | EXSCIENTIA PLC | 853,050 | $4,547 | 3.1% | $18.64 | — | ADS | 30223G102 |
| XENE | XENON PHARMACEUTICALS INC | 114,380 | $4,510 | 3.1% | $18.43 | +97.6% | COM | 98420N105 |
| — | SOMALOGIC INC | 1,696,558 | $4,258 | 2.9% | $12.39 | — | CLASS A COM | 83444K105 |
| — | CHINOOK THERAPEUTICS INC | 113,950 | $2,985 | 2.1% | $19.66 | — | COM | 16961L106 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $2,912 | 2.0% | $17.30 | -57.8% | COM CL A | 753018100 |
| INCY | INCYTE CORP | 34,391 | $2,762 | 1.9% | $67.41 | +13.5% | COM | 45337C102 |
| ONC | BEIGENE LTD | 12,022 | $2,644 | 1.8% | $265.35 | — | SPONSORED ADR | 07725L102 |
| — | IVERIC BIO INC | 111,984 | $2,398 | 1.7% | $9.62 | — | COM | 46583P102 |
| — | EARGO INC | 2,958,099 | $1,701 | 1.2% | $38.96 | — | COM | 270087109 |
| — | BOLT BIOTHERAPEUTICS INC | 1,166,952 | $1,517 | 1.0% | $15.46 | — | COM | 097702104 |
| — | AEROVATE THERAPEUTICS INC | 50,616 | $1,483 | 1.0% | $29.30 | — | COM | 008064107 |
| — | MERUS N V | 93,750 | $1,450 | 1.0% | $15.47 | — | COM | N5749R100 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 136,655 | $1,118 | 0.8% | $24.13 | -64.3% | COM | 69404D108 |
| EXEL | EXELIXIS INC | 64,200 | $1,030 | 0.7% | $23.32 | -30.1% | COM | 30161Q104 |
| TRDA | ENTRADA THERAPEUTICS INC | 73,582 | $995 | 0.7% | $9.39 | — | COM | 29384C108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 32,520 | $947 | 0.7% | $25.70 | 0.0% | COM | 76243J105 |
| GRTX | GALERA THERAPEUTICS INC | 613,223 | $914 | 0.6% | $8.13 | -80.0% | COM | 36338D108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 6,115 | $633 | 0.4% | $82.51 | +13.8% | COM | 09061G101 |
| — | DBV TECHNOLOGIES S A | 370,950 | $568 | 0.4% | $5.33 | — | SPONSORED ADR | 23306J101 |
| — | FIBROGEN INC | 34,106 | $546 | 0.4% | $14.28 | — | COM | 31572Q808 |
| TVTX | TRAVERE THERAPEUTICS INC | 25,606 | $538 | 0.4% | $21.19 | 0.0% | COM | 89422G107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 78,720 | $532 | 0.4% | $26.16 | -79.5% | COM | 483497103 |
| ASND | ASCENDIS PHARMA A/S | 4,168 | $509 | 0.4% | $134.52 | — | SPONSORED ADR | 04351P101 |
| BMEA | BIOMEA FUSION INC | 60,000 | $506 | 0.3% | $8.53 | 0.0% | COM | 09077A106 |
| ACAD | ACADIA PHARMACEUTICALS INC | 29,984 | $477 | 0.3% | $20.11 | -22.3% | COM | 004225108 |
| ALXO | ALX ONCOLOGY HLDGS INC | 41,950 | $473 | 0.3% | $60.98 | -81.6% | COM | 00166B105 |
| — | AFFIMED N V | 372,472 | $462 | 0.3% | $1.92 | — | COM | N01045108 |
| ARGX | ARGENX SE | 1,110 | $421 | 0.3% | $350.44 | — | SPONSORED ADR | 04016X101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,182 | $343 | 0.2% | $97.80 | 0.0% | COM | 558868105 |
| GTLB | GITLAB INC | 6,910 | $314 | 0.2% | $45.15 | 0.0% | CLASS A COM | 37637K108 |
| — | SATSUMA PHARMACEUTICALS INC | 177,900 | $160 | 0.1% | $4.92 | — | COM | 80405P107 |
| KOD | KODIAK SCIENCES INC | 19,622 | $140 | 0.1% | $81.98 | -91.2% | COM | 50015M109 |
| ABCL | ABCELLERA BIOLOGICS INC | 12,521 | $127 | 0.1% | $15.18 | -23.9% | COM | 00288U106 |
| NRIX | NURIX THERAPEUTICS INC | 11,500 | $126 | 0.1% | $12.06 | 0.0% | COM | 67080M103 |
| — | SYNLOGIC INC | 68,634 | $52 | 0.0% | $3.89 | — | COM | 87166L100 |
| CERS | CERUS CORP | 14,172 | $52 | 0.0% | $5.54 | -31.9% | COM | 157085101 |
| — | INVITAE CORP | 11,337 | $21 | 0.0% | $32.19 | — | COM | 46185L103 |